ITEMS IN AFP WITH KEYWORD:
Key clinical questions and their evidence-based answers directly from the journal's content, written by and for family physicians.
Apr 15, 2019 Issue
Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults [Putting Prevention into Practice]
A.C., a 32-year-old woman, presents for her annual wellness visit. She recently had blood work completed that showed normal glucose and lipid levels. Her blood pressure is 124/76 mm Hg, weight is 221.8 lb (100.6 kg), height is 5 feet 6 inches (172 cm), and body mass index (BMI) is 34 kg per m2; examination of her heart and lungs is normal.
Apr 15, 2019 Issue
Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.
Lorcaserin, 10 mg twice daily, helps some patients lose 10% or more of their body weight (number needed to treat [NNT] = 10) and appears to be safe in terms of cardiovascular events.
Mar 1, 2019 Issue
Metformin for Improving Maternal and Infant Outcomes in Pregnant Women Who Are Obese [Medicine by the Numbers]
This meta-analysis showed no clear benefit for metformin in reducing the risk of large for gestational age infants. Additionally, there was no difference in important secondary outcomes such as gestational diabetes, hypertensive disease in pregnancy, shoulder dystocia, advanced perineal lacerations,...
Aug 1, 2018 Issue
Interventions for Treatment of Overweight and Obese Children [Cochrane for Clinicians]
Interventions that include combinations of diet, physical activity, and behavior changes may reduce weight, body mass index (BMI), and BMI z-score (equivalent to BMI-for-age percentile) in overweight and obese children six to 11 years of age.
Jun 1, 2018 Issue
High-Dose vs. Standard-Dose Heparin for VTE Prophylaxis in Obese Patients [FPIN's Help Desk Answers]
In most patients weighing more than 220 lb (100 kg), high-dose heparin prophylaxis (7,500 units subcutaneously three times per day) does not further reduce the risk of VTE compared with standard-dose heparin (5,000 units subcutaneously two or three times per day).
Pregnant women who are obese have nearly double the rate of cesarean delivery, and obesity increases the median duration of active labor by up to four hours when labor is induced. The difference in cesarean delivery rate is larger in obese primigravida patients presenting with cervical dilation of less than 1 cm.
As obesity becomes more common, it is important for all maternity care clinicians to understand the risks and associated management of obesity in pregnancy. Elevated prepregnancy weight increases the absolute risk of many adverse fetal and maternal outcomes.
Oct 15, 2017 Issue
Screening for Obesity in Children and Adolescents: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF recommends that clinicians screen for obesity in children and adolescents 6 years and older, and offer or refer them to comprehensive, intensive behavioral interventions to promote improvements in weight status.